Clinical Trial Details

EORTC-26101

Back to Clinical Trials Database

Phase III trial exploring the combination of bevacizumab and lomustine in patients with first recurrence of a glioblastoma – (previously: Phase II trial exploring the sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma)

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 07-Oct-2011
Date Step1 close: 07-Jan-2015
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 592 - All Groups: 592
Treatment Bevacizumab, Lomustine
Study Staff
Type of cancer
Participating groups EORTC Brain Tumor Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT01290939
NCT number NCT01290939
EudraCT 2010-023218-30